QUESTIONS · SOURCED
Sermorelin questions, answered from the record
Direct answers on mechanism, status, efficacy, and safety — each grounded in a cited study.
How does sermorelin work to stimulate growth hormone production?
Sermorelin binds GHRH receptors on the pituitary's growth-hormone-making cells and activates the cAMP/PKA pathway, prompting the gland to release its own growth hormone in natural pulses while feedback through somatostatin and IGF-1 stays intact [6]. In growth-hormone-deficient children, once-daily subcutaneous sermorelin accelerated growth without excessive IGF-1 generation [1].
Is sermorelin FDA approved?
Historically yes, as a branded product (NDA on file) for pediatric growth-hormone deficiency; that product was withdrawn from the US market in 2008 for commercial reasons [5][9]. It is not currently sold as a finished FDA-approved drug, but is available through compounding as a Category 1 bulk substance under FDA's interim Section 503A policy [9]. An editorial cautions that GH-secretagogue anti-aging use is "not yet ready for prime time" [5].
Why was the branded sermorelin product discontinued?
The formerly-approved branded sermorelin product was withdrawn from the US market in 2008 for commercial (business) reasons — not because of safety or efficacy problems [5][9]. A 2009 clinical review noted that this left no commercially available recombinant GHRH in the US and discussed the diagnostic consequences for adult GH-deficiency testing, including a shift to alternative stimulation tests [8].
Is sermorelin legal?
Sermorelin is treated as a Category 1 bulk drug substance under FDA's interim Section 503A compounding policy (final guidance January 2025), so it can be compounded for individual patients [9]. It is prohibited in sport under WADA's S2 class [11]. An Annals of Internal Medicine editorial separately cautions that secretagogue use for aging is not yet evidence-justified [5].
What is sermorelin?
Sermorelin is the amidated 29-amino-acid amino-terminal fragment of growth hormone-releasing hormone (GHRH) — the shortest fragment that keeps full activity at the GHRH receptor [6]. It is a growth-hormone secretagogue: it prompts the body's own pituitary to release growth hormone rather than supplying growth hormone directly [6].
What does sermorelin do to the body?
It stimulates the pituitary to make and release the body's own growth hormone in its natural pulsatile pattern, which in turn raises IGF-1 through the GH/IGF-1 axis [6]. In growth-hormone-deficient children this accelerated linear growth [1]; in older men, twice-daily subcutaneous dosing for 14 days raised 24-hour GH and IGF-1 toward young-adult levels [2].
Does sermorelin work?
In its approved historical use, yes: it accelerated growth in growth-hormone-deficient children [1]. In healthy older men, 0.5 mg and 1 mg subcutaneously twice daily for 14 days produced dose-related GH and IGF-1 increases, with high-dose parameters no longer differing from young men [2]. For adult anti-aging goals, rigorous long-term evidence is limited [5].
How long does it take for sermorelin to work?
A single dose elevates serum GH for about 3 hours despite the peptide's short ~10-12 minute plasma half-life [3]. Measurable GH/IGF-1 changes appeared over a 14-day course in older men [2]. Growth outcomes in children were measured across the first year of therapy [1]. Timelines for any other goal are not established in controlled trials.
How does sermorelin compare to CJC-1295?
Both target the GHRH pathway, but CJC-1295 with DAC uses albumin-binding (Drug Affinity Complex) technology to extend its half-life to multiple days, whereas native sermorelin clears in minutes [3]. The short half-life of GHRH(1-29) is precisely what motivated longer-acting analogs like the DAC-modified form [3]. Sermorelin preserves a more natural pulsatile pattern [4].
Sermorelin vs ipamorelin: what is the difference?
They act on different receptors. Sermorelin is a GHRH analog working at the GHRH receptor on pituitary cells [6]; ipamorelin is a growth-hormone-releasing peptide acting at the separate ghrelin/GHS receptor. Both are GH secretagogues and are often discussed together, but they are distinct mechanisms and are not interchangeable.
What is sermorelin used for?
Its approved historical use was diagnosing and treating growth-hormone deficiency in children, where subcutaneous sermorelin accelerated growth [1]. It has also been studied in adult GH-axis research, aging, and cognition [2][7]. Adult anti-aging and body-composition use is off-label and investigational, and the long-term evidence is limited [5].
Does sermorelin actually help with sleep, or is it waking me up instead?
Controlled trials of sermorelin focused on GH/IGF-1 and growth outcomes, not on sleep as a primary endpoint, so there is no strong sermorelin-specific sleep claim to cite [2]. Growth hormone is naturally released during deep sleep, which is part of why studies dosed at bedtime [1], but sleep effects people describe are anecdotal and not established by controlled data.
Why is it recommended to inject sermorelin at night?
Studies commonly timed dosing at bedtime because growth hormone is secreted in pulses, especially during early, slow-wave sleep, so administration was aligned with that natural rhythm [1]. This is the rationale reported in the research; it is context for interpreting the studies, not a personal dosing instruction.
Does sermorelin burn fat?
Direct controlled fat-loss data for sermorelin itself are limited. A closely related GHRH analog (tesamorelin) reduced percent body fat by 7.4% over 20 weeks in older adults [7]. A 2026 review of therapeutic peptides frames such metabolic uses as promising but needing further study before most unapproved peptides can be used safely in humans [10].
Is sermorelin effective for weight loss?
There is no established controlled evidence that sermorelin causes weight loss; the body-composition signal comes mainly from the related analog tesamorelin, not sermorelin itself [7]. A 2026 review notes that alongside rigorously approved peptide drugs, many novel unapproved peptides still lack the safety and efficacy data needed for routine human use [10].
Does sermorelin affect testosterone?
The sermorelin trials measured the GH/IGF-1 axis, not testosterone, so there is no direct sermorelin-testosterone finding to cite. In older men, twice-daily subcutaneous GHRH(1-29) for 14 days raised 24-hour GH and IGF-1 without altering fasting glucose [2]; any testosterone effect is not part of that controlled record.
Will sermorelin raise my IGF-1 levels?
In healthy older men, subcutaneous GHRH(1-29) at 0.5 mg and 1 mg twice daily for 14 days produced dose-related increases in 24-hour GH and IGF-1; after high-dose treatment these no longer differed from young men [2]. Because sermorelin works through the body's own feedback-regulated axis, the pediatric study saw growth acceleration without excessive IGF-1 generation [1].
Does sermorelin build muscle?
Controlled muscle-mass data for sermorelin specifically are limited. The clearer body-composition signal is from the related analog tesamorelin (reduced percent body fat over 20 weeks), not sermorelin [7]. A 2026 review treats most unapproved peptides for such goals as promising but not yet established for safe human use [10].
How does sermorelin differ from direct HGH injections?
Sermorelin stimulates the body's own pituitary to release growth hormone in natural pulses, preserving feedback through somatostatin and IGF-1, whereas recombinant growth hormone supplies the hormone directly and bypasses that regulation [6]. An editorial argues sermorelin's preserved pulsatility may be a more physiologic approach to adult GH insufficiency than recombinant growth hormone [4].
Does sermorelin affect the brain?
Sermorelin acts on the pituitary, but GHRH-pathway stimulation has been linked to cognition in research. In a randomized controlled trial, 20 weeks of a daily GHRH analog improved cognition in older adults (P=0.03) [7], and in aged rodents a stabilized GHRH analog attenuated age-related spatial-memory deficits [13]. These used analogs and models, not necessarily sermorelin in humans.
Can sermorelin or GHRH improve cognition in older adults?
In a randomized, double-blind, placebo-controlled trial of 152 older adults (66 with mild cognitive impairment), 20 weeks of daily subcutaneous GHRH analog had a favorable effect on cognition (P=0.03), raised IGF-1 by 117% within the physiologic range, and reduced body fat by 7.4%, with mild adverse events [7]. The trial used a stabilized analog rather than sermorelin itself.
What are the side effects of sermorelin?
Reported side effects in the human literature are generally mild, with injection-site reactions most common on the subcutaneous route [1][2]. Beyond that, GH and IGF-1 are mitogenic, so chronically raising them carries a recognized theoretical oncologic consideration for any GH-axis intervention [6]. An editorial cautions that secretagogue anti-aging use is not yet evidence-justified [5].